基于数据挖掘分析李其信治疗勃起功能障碍用药规律
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R698+.1

基金项目:

深圳市科技计划项目(JCYJ20180302144752020);深圳市宝安中医药发展基金项目(2020KJCX-KTYJ-16);深圳市宝安区科技创新 局项目(2020JD481);深圳市宝安区中医院PI团队项目(BAZYY20200610)


Analysis of Medication Rules of LI Qixin Treating Erectile Dysfunction Based on Data Mining
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于中医传承辅助系统V2.5 挖掘分析李其信教授治疗勃起功能障碍的用药规律。方法:收集整理李其信教授治疗勃起功能障碍患者的相关病历,筛选出112 首处方,录入中医传承辅助系统V2.5,利用该软件的集成规则分析、无监督的熵层次聚类、改进的互信息法、复杂系统熵聚类、四气五味归经分析等方法,分析挖掘李其信教授治疗勃起功能障碍的用药规律。结果:使用频数>20 次的药物共29 味,排名前10 位的药物分别是淫羊藿、柴胡、刺蒺藜、甘草、白芍、枸杞子、黄芪、锁阳、丹参、茯苓。支持度20,置信度0.6 条件下进行关联规则分析,排名前10 位的组合有淫羊藿-柴胡,淫羊藿-刺蒺藜,柴胡-刺蒺藜,淫羊藿-白芍,淫羊藿-枸杞子,白芍-柴胡,甘草-淫羊藿,甘草-柴胡,甘草-白芍,淫羊藿-柴胡-刺蒺藜。基于复杂系统熵聚类分析,获得核心药物组合为炙甘草-甘草-山萸肉,枸杞子-薏苡仁-王不留行。基于无监督熵层次聚类分析,获得2 个新处方,白芍-甘草-山萸肉-葛根,川芎-枸杞子-王不留行-远志。药物四气使用频数排序依次为温性、平性、寒性、凉性、热性,以温性为主。药物五味使用频数依次为甘味、苦味、辛味、酸味、咸味、涩味,以甘味为主。药物归经使用频数排前5 位为肝经、脾经、肾经、肺经、心经。结论:基于数据挖掘发现李其信教授治疗勃起功能障碍以健脾补肾、疏肝活血为法,常用药物性味以温平甘为主,并据其兼症加减治疗。

    Abstract:

    Abstract: Objective: To explore and analyze the medication rules of Professor LI Qixin in the treatment of erectile dysfunction based on Chinese medicine inheritance support system V2.5. Methods:Medical records related to patients with erectile dysfunction treated by Professor LI Qixin were collected and sorted out, and a total of 112 prescriptions were screened out and recorded into Chinese medicine inheritance support system V2.5. Integration rule analysis, unsupervised entropy hierarchical clustering,improved mutual information method,complex system entropy clustering,analysis of four qi,five flavors and meridian entry and other methods of the software were used to analyze and excavate the medication rules of Professor LI Qixin in the treatment of erectile dysfunction. Results: A total of 29 medicines were used for more than 20 times,and the top 10 medicines were Herba Epimedii,Radix Bupleuri,Fructus Tribuli,Radix et Rhizoma Glycyrrhizae, Radix Paeoniae Alba, Fructus Lycii, Radix Astragali, Herba Cynomorii, Radix et Rhizoma Salviae Miltiorrhizae and Poria. Association rule analysis with support degree of 20 and confidence degree of 0.6 showed that the top 10 combinations were Herba Epimedii- Radix Bupleuri, Herba Epimedii- Fructus Tribuli, Radix Bupleuri- Fructus Tribuli, Herba Epimedii- Radix Paeoniae Alba,Herba Epimedii-Fructus Lycii,Radix Paeoniae Alba-Radix Bupleuri,Radix et Rhizoma Glycyrrhizae-Herba Epimedii, Radix et Rhizoma Glycyrrhizae- Radix Bupleuri, Radix et Rhizoma Glycyrrhizae- Radix Paeoniae Alba and Herba Epimedii- Radix Bupleuri- Fructus Tribuli. Based on the analysis of complex system entropy clustering, the core medicine combinations were Radix et Rhizoma Glycyrrhizae Praeparata cum Melle- Radix et Rhizoma Glycyrrhizae- Fructus Corni and Fructus Lycii- Semen Coicis- Semen Vaccariae. Based on the analysis of unsupervised entropy hierarchical clustering, two new prescriptions were obtained, namely, Radix Paeoniae Alba- Radix et Rhizoma Glycyrrhizae- Fructus Corni- Radix Puerariae Lobatae and Rhizoma Chuanxiong-Fructus Lycii-Semen Vaccariae-Radix Polygalae. According to the frequency of use,the four qi of medicines was in the order of warm,neutral,cold,cool and hot,and was mainly warm;the five flavors of medicines was in the order of sweet,bitter,acrid,sour,salty and astringent,with sweet flavor as the main flavor;the top five meridian entry of medicines were liver meridian, spleen meridian, kidney meridian, lung meridian and heart meridian. Conclusion:Based on data mining,it is found that Professor LI Qixin treated erectile dysfunction by fortifying the spleen and tonifying the kidney, as well as soothing the liver and activating blood; the main flavors of commonly used medicines are warm,neutral and sweet,and the treatment was modified according to the symptoms.

    参考文献
    相似文献
    引证文献
引用本文

傅伟,游旭军,丁劲,远庚彦,陈树超,吴丽通,车祖钊,张泽政,陈颖雯,指导:李其信.基于数据挖掘分析李其信治疗勃起功能障碍用药规律[J].新中医,2022,54(8):21-25

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-24
  • 出版日期: